Description

2-O,4-o-(Phenylboranediyl)-α-D-Ribopyranose 1,3-Diacetate is a specialized carbohydrate derivative featuring a phenylboranediyl bridge, which imparts unique chemical functionality and stability. This compound is a critical synthetic intermediate for the development of novel nucleoside analogs, carbohydrate-based drugs, and boron-containing pharmaceuticals. It is essential for research and development teams in pharmaceutical, agrochemical, and advanced material sectors seeking to create targeted bioactive molecules. The product, with CAS No. 74825-23-3, is supplied under stringent quality control to ensure batch-to-batch consistency for demanding synthetic applications.

Application

• Pharmaceutical Intermediate: Key building block for the synthesis of boronated nucleosides and carbohydrate-based therapeutic agents.
• Protease Inhibitor Research: Used in the development of boron-containing enzyme inhibitors, particularly for serine proteases.
• Boron Neutron Capture Therapy (BNCT): Serves as a precursor for designing boron carriers in experimental cancer treatment research.
• Glycoconjugate Synthesis: Employed in the preparation of complex glycoconjugates and labeled sugars for biochemical studies.
• Agrochemical Development: Intermediate for creating novel, targeted pesticides and herbicides with specific modes of action.
• Material Science: Precursor for boron-doped organic polymers and advanced functional materials.

Basic Information

Product Name	2-O,4-o-(Phenylboranediyl)-α-D-Ribopyranose 1,3-Diacetate
CAS No.	74825-23-3
Molecular Formula	C₁₅H₁₇BO₇
Molecular Weight	320.11 g/mol
Synonyms	1,3-Di-O-acetyl-2,4-O-(phenylboranediyl)-α-D-ribopyranose; Phenylboronic Acid 2,4-Ester with 1,3-Di-O-acetyl-α-D-ribopyranose; α-D-Ribopyranose, 2,4-O-(phenylboranediyl)-, 1,3-diacetate; 2,4-O-(Phenylboranediyl)-α-D-ribopyranose 1,3-diacetate; Boronic acid, B-[2,4-bis(acetyloxy)tetrahydro-2H-pyran-3,5-diyl]-, phenyl-; 74825-23-3
EINECS	Contact for details

Quality Control

Our 2-O,4-o-(Phenylboranediyl)-α-D-Ribopyranose 1,3-Diacetate is manufactured under a strict quality management system. Each batch undergoes comprehensive analytical testing, including HPLC, NMR, and IR spectroscopy, to ensure identity, purity, and conformity to established specifications. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting critical quality attributes. We support cGMP compliance for pharmaceutical applications and can tailor specifications to meet specific project requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed under an inert atmosphere (e.g., nitrogen or argon) after opening to prevent degradation. Keep away from incompatible materials such as strong acids, strong bases, and oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.